Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl)
DPRESS Study. Case-control Study in Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients
2 other identifiers
observational
271
0 countries
N/A
Brief Summary
The purpose of this study is to evaluate the relationship between cancer pain and risk of depression among cancer patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2007
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 25, 2011
CompletedFirst Posted
Study publicly available on registry
July 26, 2011
CompletedFebruary 11, 2013
February 1, 2013
4 months
July 25, 2011
February 8, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Beck Depression Inventory
3 months
Visual scales analog (EVAs)
3 months
Secondary Outcomes (1)
Number of patients with cancer pain.
3 months
Study Arms (1)
001
Visual analogue scales (EVAs) This scale measures the pain intensity.
Interventions
Eligibility Criteria
patients with cancer pain who experience depression and pain after cancer diagnosis
You may qualify if:
- Patients =18 years old
- have medical data of = 3 months
- experience pain after cancer diagnosis and complete the Beck Depression Inventory (BDI)
- patients who give informed written consent
- patients with no mental or physical disorders that unable them to complete the BDI.
You may not qualify if:
- Patients with diagnosis of depression before cancer diagnosis
- patients with chronic pain prior to the diagnosis of cancer, and cancer disease has not changed its course
- patients with other previous mental disorders
- patients who do not give their informed written consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Janssen-Cilag S.A. (formerly Janssen Sp) Clinical Trial
Janssen-Cilag, S.A.
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 25, 2011
First Posted
July 26, 2011
Study Start
November 1, 2007
Primary Completion
March 1, 2008
Study Completion
March 1, 2008
Last Updated
February 11, 2013
Record last verified: 2013-02